Environmental Science and Pollution Research

, Volume 19, Issue 5, pp 1574–1583 | Cite as

Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes

  • Athanasios S. Stasinakis
  • Smaragdi Mermigka
  • Vasilios G. Samaras
  • Eleni Farmaki
  • Nikolaos S. Thomaidis
Research Article

Abstract

Purpose

The presence of four phenolic endocrine disrupting compounds (EDCs: nonylphenol [NP], NP monoethoxylate[NP1EO], bisphenol A [BPA], triclosan, [TCS]) and four nonsteroidal anti-inflammatory drugs (NSAIDs: ibuprofen[IBF], ketoprofen [KFN], naproxen [NPX], diclofenac [DCF]) in a Greek river receiving treated municipal wastewater was investigated in this study.

Methods

Samples were taken from four different points of the river and from the outlet of a sewage treatment plant (STP) during six sampling campaigns, and they were analyzed using gas chromatography–mass spectrometry.

Results

According to the results, EDCs were detected in almost all samples, whereas NSAIDs were detected mainly in wastewater and in the part of the river that receives wastewater from the STP. Among the target compounds, the highest mean concentrations in the river were detected for NP (1,345 ng L−1) and DCF (432 ng L−1). Calculation of daily loads of the target compounds showed that STP seems to be the major source of NSAIDs to the river, whereas other sources contribute significantly to the occurrence of EDCs. The environmental risk due to the presence of target compounds in river water was estimated, calculating risk quotients for different aquatic organisms (algae, daphnids, and fish). Results denoted the possible threat for the aquatic environment due to the presence of NP and TCS in the river.

Keywords

Emerging contaminants Surface waters Wastewater Risk assessment 

References

  1. Ahel M, Giger W, Koch M (1994) Behaviour of alkylphenol polyethoxylate surfactants in the aquatic environment—I. Occurrence and transformation in sewage treatment. Water Res 28:1131–1142CrossRefGoogle Scholar
  2. Alexander HC, Dill DC, Smith LW, Guiney PD, Dorn P (1988) Bisphenol-A: acute aquatic toxicity. Environ Toxicol Chem 7:19–26CrossRefGoogle Scholar
  3. APHA (1998) Standard methods for the examination of water and wastewater, 20th ed. American Public Health Association, Port City Press, Baltimore, Maryland, USAGoogle Scholar
  4. Arditsoglou A, Voutsa D (2010) Partitioning of endocrine disrupting compounds in inland waters and wastewaters discharged into the coastal area of Thessaloniki, Northern Greece. Environ Sci Poll Res 17:529–538CrossRefGoogle Scholar
  5. Bendz D, Paxéus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mat 122:195–204CrossRefGoogle Scholar
  6. Birkett JW, Lester JN (2003) Endocrine disrupters in wastewater and sludge treatment processes, CRC Press LLCGoogle Scholar
  7. Brooke LT (1993) Acute and chronic toxicity of nonylphenol to ten species of aquatic organisms. USEPA Draft Report, EPA Contract No 68-C1-0034Google Scholar
  8. European Union (2001) Decision No 2455/2001/EC of the European Parliament and of the council of 20 November 2001 establishing the list of priority substances in the field of water policy and amending directive 2000/60/EC, Off. J. L331, 15/12/2001Google Scholar
  9. European Union (2003) Technical Guidance Document on Risk Assessment (Part II), European Chemicals BureauGoogle Scholar
  10. European Union (2006) Proposal for a Directive of the European Parliament and of the Council on environmental quality standards in the field of water policy and amending Directive 2000/60/EC, 2006/0129, Brussels, 17.7.2006Google Scholar
  11. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Gindice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Tox Chem 23:1344–1354CrossRefGoogle Scholar
  12. Garcia-Galan MJ, Diaz-Cruz MS, Barcelo D (2011) Occurrence of sulfonamide residues along the Ebro river basin: removal in wastewater treatment plants and environmental impact assessment. Environ Int 37:462–473CrossRefGoogle Scholar
  13. Gomez MJ, Martinez Bueno MJ, Lacorte S, Fernandez-Alba AR, Aguera A (2007) Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66:993–1002CrossRefGoogle Scholar
  14. Gonzalez S, Petrovic M, Barcelo D (2007) Removal of a broad range of surfactants from municipal wastewater—comparison between membrane bioreactor and conventional activated sludge treatment. Chemosphere 67:335–343CrossRefGoogle Scholar
  15. Gros M, Petrovic M, Ginebreda A, Barcelo D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36:15–26CrossRefGoogle Scholar
  16. Halden RU, Paull DH (2005) Co-occurrence of triclocarban and triclosan in U.S. water resources. Environ Sci Technol 39:1420–1426CrossRefGoogle Scholar
  17. Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgenses SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment—a review. Chemosphere 36:357–393CrossRefGoogle Scholar
  18. Jonkers N, Kohler HPE, Dammshauser A, Giger W (2009) Mass flows of endocrine disruptors in the Glatt River during varying weather conditions. Environ Poll 157:714–723CrossRefGoogle Scholar
  19. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42:3498–3518CrossRefGoogle Scholar
  20. Kim Y, Choi K, Jung J, Park S, Kim PG, Park J (2007) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33:370–375CrossRefGoogle Scholar
  21. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. Streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211CrossRefGoogle Scholar
  22. Kopf W (1997) Wirkung endokriner stoffe in biotests mit wasserogranismen. In Stoffe mit endokriner wirkung in wasser. Bayerisches landesamt fur wasserwitschaft, Institut fur Wasserforschung Munchen (ed) OldenbourgGoogle Scholar
  23. Lindberg RH, Bjorklund K, Rendahl P, Johansson MI, Tysklind M, Andersson BAV (2007) Environmental risk assessment of antibiotics in the Swedish environment with emphasis on sewage treatment plants. Water Res 41:613–619CrossRefGoogle Scholar
  24. Loos R, Gawlik BM, Locoro G, Rimaviciute E, Contini S, Bidoglio G (2009) EU-wide survey of polar organic persistent pollutants in European river waters. Environ Pollut 157:561–568CrossRefGoogle Scholar
  25. Möder M, Braun P, Lange F, Schrader S, Lorenz W (2007) Determination of endocrine disrupting compounds and acidic drugs in water by coupling of derivatization, gas chromatography and negative-chemical ionization mass spectrometry. Clean 35:444–451Google Scholar
  26. Nassef M, Matsumoto S, Seki M, Kang IJ, Moroishi J, Shimasaki Y, Oshima Y (2009) Pharmaceuticals and personal care products toxicity to Japanese medaka fish (Oryzias latipes). J Fac Agr Kyushu U 54:407–411Google Scholar
  27. Orvos DR, Versteeg DJ, Inauen J, Capdevielle M, Rothenstein A, Cunningham V (2002) Aquatic toxicity of triclosan. Environ Toxicol Chem 21:1338–1349CrossRefGoogle Scholar
  28. Peng X, Yu Y, Tang C, Tan J, Xuang Q, Wang Z (2008) Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ 397:158–166CrossRefGoogle Scholar
  29. Pomati F, Netting AG, Calamari D, Neilan BA (2004) Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor. Aquat Toxicol 67:387–396CrossRefGoogle Scholar
  30. Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E (2008) Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 102:129–137CrossRefGoogle Scholar
  31. Pothitou P, Voutsa D (2008) Endocrine disrupting compounds in municipal and industrial wastewater treatment plants in Northern Greece. Chemosphere 73:1716–1723CrossRefGoogle Scholar
  32. Quinn B, Gagné F, Blaise C (2009) Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuate. Sci Total Environ 407:1072–1079CrossRefGoogle Scholar
  33. Samaras VG, Thomaidis NS, Stasinakis AS, Gatidou G, Lekkas TD (2010) Determination of selected non-steroidal anti-inflammatory drugs in wastewater by gas chromatography–mass spectrometry. Int J Environ Anal Chem 90:219–229CrossRefGoogle Scholar
  34. Samaras VG, Thomaidis NS, Stasinakis AS, Lekkas TD (2011) An analytical method for the simultaneous trace determination of acidic pharmaceuticals and phenolic endocrine disrupting chemicals in wastewater and sewage sludge by gas chromatography–mass spectrometry. Anal Bioanal Chem 399:2549–2561CrossRefGoogle Scholar
  35. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383–395CrossRefGoogle Scholar
  36. Singer H, Muller S, Tixier C, Pillonel L (2002) Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ Sci Technol 36:4998–5004CrossRefGoogle Scholar
  37. Staples CA, Dorn PB, Klecka GM, O’Block ST, Haris LR (1998) A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 36:2149–2173CrossRefGoogle Scholar
  38. Stasinakis AS, Gatidou G, Mamais D, Thomaidis NS, Lekkas TD (2008) Occurrence and fate of endocrine disrupters in Greek sewage treatment plants. Water Res 42:1796–1804CrossRefGoogle Scholar
  39. Stephenson RR (1983) Diphenylol propane: acute toxicity to Daphna magna and Selenastrum capricornutum. Shell group research report SBGR.83.216Google Scholar
  40. Yoon Y, Ryu J, Oh J, Choi BG, Snyder SA (2010) Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci Total Environ 408:636–643CrossRefGoogle Scholar
  41. Zhang Y, Geiben SU, Gal C (2008) Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73:1151–1161CrossRefGoogle Scholar
  42. Zhou JL, Zhang ZL, Banks E, Grover E, Jiang JK (2009) Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J Haz Mater 166:655–661CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Athanasios S. Stasinakis
    • 1
  • Smaragdi Mermigka
    • 1
  • Vasilios G. Samaras
    • 1
  • Eleni Farmaki
    • 2
  • Nikolaos S. Thomaidis
    • 2
  1. 1.Water and Air Quality Laboratory, Department of EnvironmentUniversity of the AegeanUniversity HillGreece
  2. 2.Laboratory of Analytical Chemistry, Department of ChemistryNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations